Table 4.
Patient Survival According to Treatment and Histology
| Alive | Deceased | |||
|---|---|---|---|---|
| n (%) | OS, Months (Range) | n (%) | TTD, Months (Range) | |
| Treatment* | ||||
| DS | 4 (50) | 11 (3–19) | 4 (50) | 2.5 (1–6) |
| DS-IC | 13 (76.47) | 37.8 (4–160) | 4 (23.53) | 13.5 (8–27) |
| DS-RT | 2 (100) | 34 (6–62) | / | / |
| DS-IC-RT | 2 (100) | 44.5 (24–65) | / | / |
| IC | 26 (74.28) | 34.7 (5–192) | 9 (25.72) | 13.4 (1–88) |
| IC-RT | 15 (78.94) | 45.4 (2–128) | 4 (21.06) | 36.5 (9–67) |
| Histology** | ||||
| DLBCL | 48 (68.57) | 39.3 (2–132) | 22 (31.43) | 18.9 (1–88) |
| FL | 11 (84.61) | 31.4 (6–62) | 2 (15.39) | 67 (63–72) |
| T-NHL | 3 (23.07) | 10.3 (4–15) | 10 (76.93) | 4.3 (0–8) |
| BL | 8 (66.66) | 63.25 (8–192) | 4 (33.34) | 2.9 (1–7) |
| HGBCL | 3 (50) | 34 (3–94) | 3 (50) | 10.3 (8–12) |
Notes: *Data available in 83 patients; **data available in 113 patients.
Abbreviations: OS, overall survival; TTD, time to death; DS, demolition surgery; IC, Immuno-chemotherapy; RT, radiotherapy; DLBCL, diffuse large B cell lymphoma; FL, follicular lymphoma; NHL, non Hodgkin lymphoma; BL, Burkitt lymphoma; HGBCL, high grade B cell lymphoma.